Roche Czech Republic made a net profit of CZK 252 mil in 2016, up 394% when compared to the last year. Total sales reached CZK 4,962 mil, which is down 8.88% when compared to the previous year.
Historically, the company’s net profit reached an all time high of CZK 252 mil in 2016 and an all time low of CZK 16.8 mil in 2007.
In terms of sales, Roche Czech Republic reached an all time high of CZK 5,445 mil in 2015 and an all time low of CZK 2,879 mil in 2004.
Roche Czech Republic's net profit has grown 37.9% a year on average in the last five years while sales have increased by -0.198% a year since 2011.
The firm generated its shareholders an average return on invested capital of 6.60% in the last five years.
As far as Roche Czech Republic's peers are concerned, Pfizer Czech Republic posted a net profit and sales of CZK 73.4 mil and CZK 3,243 mil in 2016, Bayer Czech Republic generated a net profit of CZK 175 mil (with sales of CZK 4,326 mil) and Amgen Czech Republic netted CZK 31.5 mil (sales of CZK 626 mil).
|Amgen Czech Republic||CZK mil||46.2||28.3||28.7||40.5||35.8|
|Bayer Czech Republic||CZK mil||166||83.4||96.2||107||123|
|GlaxoSmithKline Czech Republic||CZK mil||240||164||127||87.7||125|
|Merck Czech Republic||CZK mil||49.3||63.4||27.4||34.9||68.6|
|Novartis Czech Republic||CZK mil||41.7||50.0||52.3||82.2||82.7|
|Pfizer Czech Republic||CZK mil||231||48.1||144||134||75.4|
|Roche Czech Republic||CZK mil||50.5||38.7||135||94.9||51.0||...|
|Sanofi-Aventis Czech Republic||CZK mil||55.1||45.2||65.2||1.19||58.6|
|Servier Czech Republic||CZK mil||...||...||12.8||13.6||13.6||15.9|